Cancer incidence in Spain, 2015

• J. Galceran ^[2] ; A. Ameijide ^[2] ; M. Carulla ^[2] ; A. Mateos ^[3] ; J. R. Quirós ^[4] ; D. Rojas ^[5] ; A. Alemán ^[6] ; A. Torrella ^[7] ; M. Chico ^[8] ; M. Vicente ^[1] ; J. M. Díaz ^[9] ; N. Larrañaga ^[10] ; R. Marcos-Gragera ^[11] ; María José Sánchez Pérez ; J. Perucha ^[12] ; P. Franch ^[13] ; C. Navarro ^[14] ; E. Ardanaz ^[14] ; J. Bigorra ^[15] ; P. Rodrigo ^[16] ; R. Peris Bonet ^[17]
  1. [1] Tribunal Superior de Justicia de la Comunidad Valenciana

     Tribunal Superior de Justicia de la Comunidad Valenciana

     Valencia, España

     
  2. [2] Fundation Society for Cancer Research and Prevention (FUNCA)
  3. [3] Registro de Cáncer de Albacete
  4. [4] Registro de Cáncer de Asturias
  5. [5] Registro de Cáncer de Islas Canarias (Gran Canaria)
  6. [6] Registro de Cáncer de Islas Canarias (Tenerife)
  7. [7] Registro de Cáncer de Castellón
  8. [8] Registro de Cáncer de Ciudad Real
  9. [9] Registro de Cáncer de Cuenca
  10. [10] Registro de Cáncer de País Vasco
  11. [11] Epidemiology Unit and Girona Cancer Registry (UERCG)
  12. [12] Registro de Cáncer de La Rioja
  13. [13] Registro de Cáncer de Mallorca
  14. [14] CIBER of Epidemiology and Public Health (CIBERESP)Madrid
  15. [15] Registro de Cáncer de Tarragona
  16. [16] Registro de Cáncer de Zaragoza
  17. [17] Registro Español de Cáncer Infantil

  Mostrar afiliaciones +
• Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 19, Nº. 7, 2017, págs. 799-825
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Dialnet Métricas: 15 Citas
• Resumen

  • Purpose Periodic cancer incidence estimates of Spain from all existing population-based cancer registries at any given time are required. The objective of this study was to present the current situation of cancer incidence in Spain.

    Methods The Spanish Network of Cancer Registries (REDECAN) estimated the numbers of new cancer cases occurred in Spain in 2015 by applying the incidence-mortality ratios method. In the calculus, incidence data from population-based cancer registries and mortality data of all Spain were used.

    Results In 2015, nearly a quarter of a million new invasive cancer cases were diagnosed in Spain, almost 149,000 in men (60.0%) and 99,000 in women. Globally, the five most common cancers were those of colon–rectum, prostate, lung, breast and urinary bladder. By gender, the four most common cancers in men were those of prostate (22.4%), colon–rectum (16.6%), lung (15.1%) and urinary bladder (11.7%). In women, the most common ones were those of breast (28.0%), colon–rectum (16.9%), corpus uteri (6.2%) and lung (6.0%). In recent years, cancer incidence in men seems to have stabilized due to the fact that the decrease in tobacco-related cancers compensates for the increase in other types of cancer like those of colon and prostate. In women, despite the stabilization of breast cancer incidence, increased incidence is due, above all, to the rise of colorectal and tobacco-related cancers.

    Conclusion To reduce these incident cancer cases, improvement of smoking control policies and extension of colorectal cancer screening should be the two priorities in cancer prevention for the next years.